XTANT MEDICAL HOLDINGS INC XTNT
ASignal's systematic analysis rates XTNT as Neutral.
Reflects the latest available analysis · analyzed Oct 31, 2026
The case on XTNT
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong gross margin (59.39%) indicating pricing power
- Free cash flow positive at $10.13M
- Current ratio of 2.16x suggests short-term financial stability
- Price near lower Bollinger Band (0.267) indicating potential reversal
- Negative price momentum (-0.0345) and trading below both SMA20 and SMA50
- Negative operating and net margins (-18.10%, -10.17%)
- Negative ROE (-25.16%) and negative EV/EBITDA (-37.65x)
- Year-over-year revenue growth down 35%
- No news coverage or Reddit mentions, suggesting lack of market interest
See the full verdict on XTNT
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes XTNT
Most investors never get a second opinion, let alone several. ASignal runs XTNT past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.